A recent study showed that nano-vaccines that mimic necrotic cancer cells could enhance immunity in mice through the proliferation of NKG2D+ natural killer cells and CD8+ T cells, ultimately enhancing the anti-tumor effects (9). This evidence concerns the gene CD8A and neoplasm.